PeterJohnOppeltMD

Oncology • Saint Louis, MO

Hematology Oncology Fellow

Join to view full profile

Dr. Oppelt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Oppelt's full profile

Already have an account?

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 800-647-2098

Fax+1 314-362-3192

Education & Training

Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2008 - 2012
University of Missouri-Columbia School of MedicineClass of 2008

Certifications & Licensure

IL State Medical License 2020 - 2026
MO State Medical License 2015 - 2026
OH State Medical License 2008 - 2016
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Mitomycin C in Patients With Incurable p16 Positive Oropharyngeal and p16 Negative Head and Neck Squamous Cell Carcinoma (HNSCC) Resistant to Standard Therapies Start of enrollment: 2015 Apr 14
ACTIVE_NOT_RECRUITING
PHASE2

Publications & Presentations

PubMed

Neoadjuvant BMS-813160, nivolumab, gemcitabine and nab-paclitaxel for patients with pancreatic cancer.
Patrick M Grierson, Crystal Wolf, Rama Suresh, Andrea Wang-Gillam, Benjamin R Tan
Clinical Cancer Research. 2025-03-24
Long-Term Outcomes After Elective Contralateral Neck Dissection for HPV-Related Oropharyngeal Cancer.
Ray Y Wang, Molly E Heft Neal, Wade L Thorstad, Hiram A Gay, Anthony J Apicelli
Otolaryngology--Head and Neck Surgery. 2025-03-19
Tazemetostat, a Selective EZH2 Inhibitor, in Combination with Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 1 Trial.
Peter J Oppelt, Sidharth V Puram, Jingxia Liu, Jessica C Ley, Douglas Adkins
Cancers. 2025-01-27

Journal Articles

Outcomes of Patients with Single-Node Metastasis of Human Papillomavirus–Related Oropharyngeal Cancer Treated with Transoral Surgery
Peter Oppelt, Kevin Palka, JAMA Otolaryngology–Head & Neck Surgery

Press Mentions

Safety and Efficacy of Zimberelimab (AB122) in Combination with Domvanalimab (AB154) and Etrumadenant (AB928) in Patients with Previously Treated Non-Small Cell Lung CancerMarch 10th, 2021